Neurocrine Biosciences
NBIX
#1602
Rank
A$19.96 B
Marketcap
A$200.20
Share price
-1.04%
Change (1 day)
-13.85%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company